Fig. 6
From: Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease
Boc2-treatment increases the expression of Aβ-degrading enzymes in APP/PS1 double-transgenic mice. (a, b) insulin-degrading enzyme (Ide) and (c, d) neprilysin (Nep) mRNA expression in the hippocampus and cortex of 29-week-old APP/PS1 double-transgenic mice or WT mice with or without Boc2 treatment. Statistical significance was determined using two-way ANOVA with turkey test. Data represent mean + SEM; n ≥ 6; *p < 0.05, **p < 0.01, ***p < 0.001 as indicated